SMTL ID : 4ytc.1

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.16 Å

Oligo State

monomer

Ligands

1 x 4HW: N~3~-phenyl-1-[6-(phenylamino)pyrimidin-4-yl]-1H-1,2,4-triazole-3,5-diamine(Non-covalent)

4HW.1: 12 residues within 4Å: Chain A: L.19, V.27, A.44, V.75, M.93, E.94, Y.95, L.96, G.99, R.144, L.147, D.158 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.19, A:L.19, A:V.27, A:Y.95 Hydrogen bonds: A:E.94, A:L.96, A:L.96, A:D.158, A:D.158, A:D.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Farmer, L.J. et al., Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases. J.Med.Chem. (2015)

Release Date

2015-08-12

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence